Kletter K - Search Results

1

[Analysis of the convergence relation of reconstructed algorithms disregarding local and global visual evaluations].

Jank J, Backfrieder W, Bergmann H, Kletter K. Jank J, et al. Among authors: kletter k. Z Med Phys. 2001;11(4):246-54. doi: 10.1016/s0939-3889(15)70524-6. Z Med Phys. 2001. PMID: 11820181 German.

2

PET based volume segmentation with emphasis on the iterative TrueX algorithm.

Knäusl B, Hirtl A, Dobrozemsky G, Bergmann H, Kletter K, Dudczak R, Georg D. Knäusl B, et al. Among authors: kletter k. Z Med Phys. 2012 Feb;22(1):29-39. doi: 10.1016/j.zemedi.2010.12.003. Epub 2011 Jan 19. Z Med Phys. 2012. PMID: 21251804 Free article.

3

[Recommendations for carrying out nuclear medicine kidney function tests with a gamma camera and computer].

Bergmann H, Mostbeck A, Kletter K, Nicoletti R, Oberladstätter M. Bergmann H, et al. Among authors: kletter k. Acta Med Austriaca Suppl. 1991;43:suppl 1-19. Acta Med Austriaca Suppl. 1991. PMID: 1763586 German.

4

The distal colon provides reserve storage capacity during colonic fluid overload.

Hammer J, Pruckmayer M, Bergmann H, Kletter K, Gangl A. Hammer J, et al. Among authors: kletter k. Gut. 1997 Nov;41(5):658-63. doi: 10.1136/gut.41.5.658. Gut. 1997. PMID: 9414974 Free PMC article.

5

[Hybrid imaging for endocrine diseases: new perspectives].

Kainberger F, Kurtaran A, Kienast O, Dobrozemsky G, Czerny C, Kletter K. Kainberger F, et al. Among authors: kletter k. Wien Klin Wochenschr. 2003;115 Suppl 2:87-90. Wien Klin Wochenschr. 2003. PMID: 15518153 Review. German.

6

[FDG-PET in oncology. Methodological principles and clinical applications].

Kletter K, Becherer A. Kletter K, et al. Radiologe. 1999 Jul;39(7):600-9. doi: 10.1007/s001170050556. Radiologe. 1999. PMID: 10472089 Review. German.

7

FDG positron emission tomography in patients with systemic mastocytosis.

Zettinig G, Becherer A, Szabo M, Uffmann M, Dudczak R, Valent P, Kletter K. Zettinig G, et al. Among authors: kletter k. AJR Am J Roentgenol. 2002 Nov;179(5):1235-7. doi: 10.2214/ajr.179.5.1791235. AJR Am J Roentgenol. 2002. PMID: 12388504

8

Evaluating repetitive 18F-fluoroazomycin-arabinoside (18FAZA) PET in the setting of MRI guided adaptive radiotherapy in cervical cancer.

Schuetz M, Schmid MP, Pötter R, Kommata S, Georg D, Lukic D, Dudczak R, Kletter K, Dimopoulos J, Karanikas G, Bachtiary B. Schuetz M, et al. Among authors: kletter k. Acta Oncol. 2010 Oct;49(7):941-7. doi: 10.3109/0284186X.2010.510145. Acta Oncol. 2010. PMID: 20831481 Clinical Trial.

9

18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) for staging and follow-up of marginal zone B-cell lymphoma.

Hoffmann M, Kletter K, Becherer A, Jäger U, Chott A, Raderer M. Hoffmann M, et al. Among authors: kletter k. Oncology. 2003;64(4):336-40. doi: 10.1159/000070290. Oncology. 2003. PMID: 12759529

10

2-18fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: an update of the prospective multicentric SEMPET trial.

De Santis M, Becherer A, Bokemeyer C, Stoiber F, Oechsle K, Sellner F, Lang A, Kletter K, Dohmen BM, Dittrich C, Pont J. De Santis M, et al. Among authors: kletter k. J Clin Oncol. 2004 Mar 15;22(6):1034-9. doi: 10.1200/JCO.2004.07.188. J Clin Oncol. 2004. PMID: 15020605

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

186 results

Search Page

Filters